Prevalence, Clinical Features, and Prognosis of Coronary Artery Embolism With Concomitant Atrial Fibrillation

CompletedOBSERVATIONAL
Enrollment

5,163

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Coronary Artery EmbolismAcute Myocardial Infarction Type 2
Interventions
OTHER

Is it coronary artery embolism

"This observational study categorizes patients with acute myocardial infarction (AMI) into three distinct groups based on their clinical characteristics:~1. Group 1: Patients with atrial fibrillation (AF) and coronary artery embolism (CAE).~2. Group 2: Patients with AF but non-coronary artery embolism myocardial infarction (non-CAE MI).~3. Group 3: Patients without AF and non-coronary artery embolism myocardial infarction (non-CAE MI without AF).~A key innovation of this study compared to previous research is its expanded eligibility criteria for AMI patients. Earlier studies typically focused exclusively on ST-segment elevation myocardial infarction (STEMI). In contrast, this investigation encompasses a broader spectrum of acute myocardial infarction, including both STEMI and non-ST-segment elevation myocardial infarction (NSTEMI). This comprehensive approach enhances the generalizability and applicability of the findings by capturing a wider range of clinical scenarios."

Trial Locations (2)

315010

The First affiliated Hospital of Ningbo University, Ningbo

Unknown

First Affiliated Hospital of Ningbo University, Ningbo

All Listed Sponsors
lead

First Affiliated Hospital of Ningbo University

NETWORK

NCT06845956 - Prevalence, Clinical Features, and Prognosis of Coronary Artery Embolism With Concomitant Atrial Fibrillation | Biotech Hunter | Biotech Hunter